MODERN SCIENTIFIC VIEWS ON THE CLINIC, SYSTEMATICS, DIAGNOSIS AND PATHOPERSONALOGY OF ENDOGENOUS PSYCHOSIS WITH EPISODIC COURSE (LITERATURE RIVIEW)

  • В.Л. Підлубний MD, PhD, Professor of the Department of Psychiatry, Psychotherapy, General and Medical Psychology, Narcology and Sexology, Zaporizhzhia State Medical University, Ukraine Address: Zaporizhzhia, Mayakovsky Avenue 26
  • Микола Хоміцький MD, PhD, Associate Professor of the Department of Psychiatry, Psychotherapy, General and Medical Psychology, Narcology and Sexology, Zaporizhzhіa State Medical University, Ukraine. Address: Mayakovsky Ave., 26
Keywords: endogenous psychoses, clinic, systematics, pathopersonalogical features

Abstract

The aim of the study. To study the literature in order to identify modern scientific views on the clinic, systematics, diagnosis and pathopersonalogy of endogenous psychoses with episodic course. Results. The analysis of the literature shows that the diagnostic and classification approaches of endogenous psychoses with episodic course, are focused on polymorphic and variable symptoms of exacerbation of the disease. This leads to diagnostic mistakes, errors in the appointment of maintenance therapy, deterioration of compliance and further deepening of social maladaptation of patients. Refusal to develop the mechanisms of pathogenesis on the basis of the nosological approach will inevitably lead to a regression of the level of treatment and rehabilitation approaches - from ethiopathogenetic to symptomatic. Conclusions. Thus, at present, the importance of diagnostic techniques aimed at assessing and differentiating persistent symptoms of the disease in the period of remission of endogenous psychoses and relate to pathopersonalogical transformations. Research and correct diagnostic assessment of this multicomponent cluster of psychopathological symptoms allows to assess the nosological affiliation of a particular clinical case and to determine the necessary pharmacological and social rehabilitation effects in order to correct existing pathopersonalogical transformations and prevent exacerbation of endogenous psychosis.

References

1. Марута Н. О., Лінська К. І. Сучасні напрямки у розробці інструментів для об'єктивної діагностики афективних розладів (огляд літератури). Український вісник психоневрології. 2018. Т. 26, Вип. 1. С. 110–115.
2. Марута Н. О., Панько Т. В., Федченко В. Ю., Семікіна О. Є. Клініко-психопатологічні прогностичні фактори перебігу первинних депресивних розладів. Психічне здоров’я. 2017. Т. 2, Вип. 51. С. 117–119.
3. Сумарокова М. А., Хритипин Д. Ф. Особенности лекарственного патоморфоза ремиссий у больных с шизоаффективными расстройствами. Человек и лекарство : сб. материалов XXI Рос. нац. конгресса. (г. Москва, 7–11 апреля 2014 г.). М., 2014. С. 188.
4. Salamon S., Santelmann H., Franklin J., Baethge C. Test-retest reliability of the diagnosis of schizoaffective disorder in childhood and adolescence - A systematic review and meta-analysis. J Affect Disord. 2018. № 230. P. 28–33. doi:10.1016/j.jad.2017.12.070. Epub 2018 Jan 3. Review. PubMed PMID: 29360577.
5. Peterson D. L., Webb C. A., Keeley J. W. et al. The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial. Schizophrenia Research. 2019. Vol. 208. P. 235–241. DOI: 10.1016/j.schres.2019.02.011.
6. World Health Organization. ICD-10 International Classification of Diseases. Version: 2010. URL : http://apps.who.int/classifications/icd10/browse/2010/en#/V
7. Кузнецова С. Л., Коцюбинский А. П., Петрова Н. Н. Комплексный диагностический подход к оценке биопсихосоциального функционирования больных с эндогенными психическими расстройствами с позиций функционального диагноза. Часть 1. Медицинская психология в России. 2018. T. 10, № 4. C. 5. DOI: 10.24411/2219-8245-2018-14050.
8. Chen Y., Farooq S., Edwards J. et al. Patterns of symptoms before a diagnosis of first episode psychosis: a latent class analysis of UK primary care electronic healthrecords. BMC Med. 2019. № 17 (1). P. 227. DOI: 10.1186/s12916-019-1462-y.
9. Колядко С. П., Малюта Л. В. Особливості клінічної картини шизофренії з депресивними порушеннями залежно від тривалості патологічного процесу. Український вісник психоневрології. 2018. Т. 26, Вип. 4 (97). С. 52–56.
10. Опря Є. В. Особливості усвідомлення психічної та соматичної хвороби у хворих на шизофренію, поєднану з цукровим діабетом / Є. В. Опря, М. М. Пустовойт // Архів психіатрії. - 2018. - Т. 24, № 4. - С. 197-201.
11. Strassnig M., Kotov R., Cornaccio D. et al. Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar Disord. 2017. № 19 (5). P.336–343. DOI: 10.1111/bdi.12505.
12. Anderson A. E., Marder S., Reise S. P. et al. Bifactor Modeling of the Positive and Negative Syndrome Scale: Generalized Psychosis Spans Schizoaffective, Bipolar, and Schizophrenia Diagnoses. Schizophr Bull. 2018. № 44 (6). P. 1204-1216. DOI:10.1093/schbul/sbx163.
13. Mistry S., Harrison J. R., Smith D. J. et al. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review. J Affect Disord. 2018. № 234. P. 148–155. DOI: 10.1016/j.jad.2018.02.005.
14. Spellmann I., Riedel M., Städtler J. et al. Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment. Cogn Neuropsychiatry. 2017. № 22 (4). P. 280–297. DOI:10.1080/13546805.2017.1322502.
15. Jonas K. G., Lencz T., Li K. et al. Schizophrenia polygenic risk score and 20-year course of illness inpsychotic disorders. Transl Psychiatry. 2019. № 9 (1). P. 300. DOI: 10.1038/s41398-019-0612-5.
16. Зубатюк О. В., Пилягіна Г. Я. Порушення управління емоціями і соціального функціонування при психозах з депресивно-параноїдною симптоматикою. Психосоматична медицина та загальна практика. 2018. Т. 3, № 4. С. 1–7. URI: http://lib.inmeds.com.ua:8080/jspui/handle/lib/9000.
17. Harrow M., Grossman L. S., Herbener E. S., Davies E. W. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry. 2000. № 177. P. 421–426.
18. Santelmann H., Franklin J., Bußhoff J., Baethge С. Test-retest reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression – a systematic review and meta-analysis. Bipolar Disorder. 2015. Vol. 17 (7). P. 753–768.
19. Baethge C. How reasonable is it to uphold the diagnostic concept of schizoaffective disorder? Bipolar Disord. 2020. № 30. doi: 10.1111/bdi.12920.
20. Чугунов В. В. Генез, коморбидность, патопластика и фон психических заболеваний. Мужское здоровье, гендерная и психосоматическая медицина. 2015. № 1–2 (02). С 57–65.
21. Correll C. U., Schooler N. R. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatr Dis Treat. 2020. № 16. P. 519–534. DOI: 10.2147/NDT.S225643.
22. Guessoum S. B., Le Strat Y., Dubertret C., Mallet J. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020. № 99. DOI: 10.1016/j.pnpbp.2020.109862.
23. Rosengard R. J., Malla A., Mustafa S., Iyer S. N. et al. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis. JAMA Psychiatry. 2019. № 76 (1). P. 61–70. DOI: 10.1001/jamapsychiatry.2018.2552.
24. Daneault J. G., Maraj A., Lepage M. et al. Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms. Acta Psychiatr Scand. 2019. № 139 (4). P. 336–347. DOI:10.1111/acps.13011.
25. Belteczki Z., Rihmer Z., Ujvari J. Clinical features of psychotic and non-psychotic bipolar patients. Neuropsychopharmacol Hung. 2017. № 19 (2). P. 86–94.
26. Sheffield J. M., Karcher N. R., Barch D. M. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective. Neuropsychol Rev. 2018. № 28 (4). P. 509–533. DOI: 10.1007/s11065-018-9388-2.
27. Woodward N. D. The course of neuropsychological impairment and brain structure abnormalities in psychotic disorders. Neurosci Res. 2016. № 102. P. 39–46. DOI: 10.1016/j.neures.2014.08.006.
28. Moritz S., Klein J. P., Lysaker P. H., Mehl S. Metacognitive and cognitive-behavioral interventions for psychosis: new developments. Dialogues Clin Neurosci. 2019. № 21 (3). P. 309–317. DOI: 10.31887/DCNS.2019.21.3/smoritz.
29. Buck B, Gagen EC, Luther L, Kukla M, Lysaker PH. Dynamic relationships between emotional distress, persecutory ideation, and metacognition in schizophrenia. J Clin Psychol. 2020. № 76 (4). P. 716–724. DOI: 10.1002/jclp.22904.
30. Berk L., Hallam K. T., Venugopal K. et al. Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder. Bipolar Disord. 2017. № 19 (3). P. 184–197. DOI: 10.1111/bdi.12486.
31. Foti D., Perlman G., Bromet E. J. et al. Pathways from performance monitoring to negative symptoms and functional outcomes in psychotic disorders. Psychol Med. 2020. № 22. P. 1–11. DOI: 10.1017/S0033291720000768.
32. Yanos P. T., DeLuca J. S., Roe D., Lysaker P. H. The impact of illness identity on recovery from severe mental illness: A review of the evidence. Psychiatry Res. 2020. № 288. DOI: 10.1016/j.psychres.2020.112950.
33. Watters C. A., Bagby R. M., Sellbom M. Meta-analysis to derive an empirically based set of personality facet criteria for the alternative DSM-5 model for personalitydisorders. Personal Disord. 2019. № 10 (2). P. 97–104. DOI: 10.1037/per0000307.
34. Hopwood C. J., Kotov R., Krueger R. F. et al. The time has come for dimensional personality disorder diagnosis. Personal Ment Health. 2018. № 12 (1). P. 82–86. DOI: 10.1002/pmh.1408.
35. Simonsen E., Newton-Howes G. Personality Pathology and Schizophrenia. Schizophr Bull. 2018. № 44 (6). P. 1180–1184. DOI: 10.1093/schbul/sby053.
36. Vrbova K., Prasko J., Ociskova M., Holubova M. Comorbidity of schizophrenia and social phobia - impact on quality of life, hope, and personality traits: a cross sectional study. Neuropsychiatr Dis Treat. 2017. № 13. P. 2073–2083. DOI: 10.2147/NDT.S141749.
37. Gøtzsche-Astrup O., Moskowitz A. Personality disorders and the DSM-5 : Scientific and extra-scientific factors in the maintenance of the status quo. Aust N Z J Psychiatry. 2016. № 50 (2). P. 119–127. DOI: 10.1177/0004867415595872.
38. Stanton K., McDonnell C. G., Hayden E. P., Watson D. Transdiagnostic approaches to psychopathology measurement: Recommendations for measure selection, data analysis, and participant recruitment. J Abnorm Psychol. 2020. № 129 (1). P. 21–28. DOI: 10.1037/abn0000464.
39. Чугунов В. В., Киреева Е. Н. Медико-психологические предикторы продромального периода повторного эпизода рекуррентного депрессивного расстройства. Запорожский медицинский журнал. 2014. № 3. С. 71–76.
40. Zettl M., Volkert J., Vögele C. et al. Mentalization and criterion a of the alternative model for personality disorders: Results from a clinical and nonclinical sample. Personal Disord. 2020. № 11 (3). P. 191–201. DOI: 10.1037/per0000356.
41. Potvin S., Aubin G., Stip E. Subjective cognition in schizophrenia. Encephale. 2017. № 43 (1). P. 15–20. DOI: 10.1016/j.encep.2016.01.002.
42. Favrod J., Nguyen A., Chaix J. et al. Improving Pleasure andMotivation in Schizophrenia: A Randomized Controlled Clinical Trial. PsychotherPsychosom. 2019. № 88 (2). P. 84–95. DOI: 10.1159/000496479.
43. Lambert C., Da Silva S., Ceniti A. K. et al. Anhedonia in depression and schizophrenia: A transdiagnostic challenge. CNS Neurosci Ther. 2018. № 24 (7). P. 615–623. DOI: 10.1111/cns.12854.
44. Sfetcu R., Musat S., Haaramo P. et al. Overview of post-discharge predictors for psychiatric re-hospitalisations: a systematic review of the literature. BMC Psychiatry. 2017. № 17 (1). P. 227. DOI: 10.1186/s12888-017-1386-z.
Published
2020-12-30
How to Cite
Підлубний, В., & Хоміцький, М. (2020). MODERN SCIENTIFIC VIEWS ON THE CLINIC, SYSTEMATICS, DIAGNOSIS AND PATHOPERSONALOGY OF ENDOGENOUS PSYCHOSIS WITH EPISODIC COURSE (LITERATURE RIVIEW). Men’s Health, Gender and Psychosomatic Medicine, (1-2), 57-65. https://doi.org/10.37321/UJMH.2020.1-2-06